Most just lately, it's been recognized that conolidine and the above derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in very similar locations as classical opioid receptors, it binds to a big selection of endogenous opioids. Unlike most opioid receptors, this receptor functions to be a scavenger and will not activate a second